353 related articles for article (PubMed ID: 9673347)
1. Phospholipase C (EC 3.1.4.11): a malignancy linked signal transduction enzyme.
Yang H; Shen F; Herenyiova M; Weber G
Anticancer Res; 1998; 18(3A):1399-404. PubMed ID: 9673347
[TBL] [Abstract][Full Text] [Related]
2. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme.
Singhal RL; Prajda N; Yeh YA; Weber G
Cancer Res; 1994 Nov; 54(21):5574-8. PubMed ID: 7923199
[TBL] [Abstract][Full Text] [Related]
3. 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy.
Rizzo MT; Weber G
Cancer Res; 1994 May; 54(10):2611-4. PubMed ID: 8168087
[TBL] [Abstract][Full Text] [Related]
4. Increased signal transduction activity and down-regulation in human cancer cells.
Weber G; Shen F; Prajda N; Yeh YA; Yang H; Herenyiova M; Look KY
Anticancer Res; 1996; 16(6A):3271-82. PubMed ID: 9042300
[TBL] [Abstract][Full Text] [Related]
5. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.
Shen F; Look KY; Yeh YA; Weber G
Cancer Biochem Biophys; 1998 Jun; 16(1-2):1-15. PubMed ID: 9923963
[TBL] [Abstract][Full Text] [Related]
6. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
Heinrich PC; Morris HP; Weber G
Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
[TBL] [Abstract][Full Text] [Related]
7. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
Elliott WL; Weber G
Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
[TBL] [Abstract][Full Text] [Related]
8. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
Baló-Banga JM; Weber G
Cancer Res; 1984 Nov; 44(11):5004-9. PubMed ID: 6091867
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).
Prajda N; Morris HP; Weber G
Cancer Res; 1976 Dec; 36(12):4639-46. PubMed ID: 187329
[TBL] [Abstract][Full Text] [Related]
10. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
Nebigil CG
Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
[TBL] [Abstract][Full Text] [Related]
11. Amplified increase in signal transduction activity in cancer cells.
Yang H; Shen F; Weber G
Anticancer Res; 1999; 19(6B):4983-8. PubMed ID: 10697500
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat brain phosphatidylinositol-specific phospholipase C by aluminum: regional differences, interactions with aluminum salts, and mechanisms.
Nostrandt AC; Shafer TJ; Mundy WR; Padilla S
Toxicol Appl Pharmacol; 1996 Jan; 136(1):118-25. PubMed ID: 8560464
[TBL] [Abstract][Full Text] [Related]
13. Current issues in the regulation of signal transduction.
Weber G; Prajda N; Yang H; Yeh YA; Shen F; Singhal RL; Herenyiova M; Look KY
Adv Enzyme Regul; 1996; 36():33-55. PubMed ID: 8869739
[TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain.
Dwivedi Y; Pandey GN
J Pharmacol Exp Ther; 1999 Nov; 291(2):688-704. PubMed ID: 10525089
[TBL] [Abstract][Full Text] [Related]
15. A high level of cell surface phosphatidylinositol-specific phospholipase C activity is characteristic of growth-arrested 3T3 fibroblasts but not of transformed variants.
Volwerk JJ; Birrell GB; Hedberg KK; Griffith OH
J Cell Physiol; 1992 Jun; 151(3):613-22. PubMed ID: 1338336
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic phospholipase C activity: I. Evidence for coupling with cytosolic guanine nucleotide-binding protein, Gi alpha.
Akompong T; Spencer RL; McEwen BS
J Cell Biochem; 1994 Nov; 56(3):397-408. PubMed ID: 7876333
[TBL] [Abstract][Full Text] [Related]
17. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
18. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C.
Schwertz DW; Kreisberg JI; Venkatachalam MA
J Pharmacol Exp Ther; 1984 Oct; 231(1):48-55. PubMed ID: 6092605
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the signal transduction program by drugs.
Weber G; Shen F; Prajda N; Yang H; Li W; Yeh A; Csokay B; Olah E; Look KY
Adv Enzyme Regul; 1997; 37():35-55. PubMed ID: 9381980
[TBL] [Abstract][Full Text] [Related]
20. Growth-promoting effects of Ca(2+)-mobilizing agents in hepatocytes: lack of correlation between the acute activation of phosphoinositide-specific phospholipase C and the stimulation of DNA synthesis by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2 alpha.
Dajani OF; Røttingen JA; Sandnes D; Horn RS; Refsnes M; Thoresen GH; Iversen JG; Christoffersen T
J Cell Physiol; 1996 Sep; 168(3):608-17. PubMed ID: 8816915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
